08 March 2002
Patient acceptance and reliability of new Humulin/Humalog 3.0 ml pre-filled insulin pen in ten Croatian diabetes centres.
John Wyatt, Nadia Mincheva, Ante Petrusic, Ante Ivandic, Tomislav Cabrijan, Eduard Galic, Mate Sucic, Zvonko Milicevic, James MaloneMed Sci Monit 2002; 8(3): PI21-26 :: ID: 420916
Abstract
BACKGROUND: The objective of this study was to assess feature preferences,patient acceptance, reliability, and safety of the new Lilly Humulin/Humalog 3.0 ml prefilled insulinpen in a clinical setting. MATERIAL/METHODS: A total of 330 patients in Croatia with type 1 or type 2diabetes mellitus who required at least one injection of insulin per day were treated with Humulin 30/70or Humalog for 4 to 6 weeks using the new prefilled pen. Questionnaires concerning various aspects ofthe pen performance were administered at endpoint. RESULTS: The features of the Lilly 3.0 ml pen deviceranked most highly by patients (% of excellent or good ratings) were cartridge visibility (93%), attaching/replacingneedles (93%), ease of dose correction (92%), checking insulin flow (90%) and dialling of insulin dose(89%). Features of the pen device rated most highly by patients in comparison with the delivery systemsused before the study and the percentage of patients rating those features as much better or better wereease of dose correction (74%), cartridge visibility (67%), audible dialing clicks (55%) and size of dosenumbers (52%). Most respondents (78%) preferred single-unit versus two-unit dosage increments. The majorityof patients rated the new prefilled pen as being more convenient and easier to use, and indicated thatit represented a significant or modest an improvement over their previous insulin injection method. CONCLUSIONS:The results of this study indicate that the new Lilly 3.0 ml prefilled pen is acceptable for patientswho were previously using either reusable devices or the traditional syringe and vial.
Keywords: Adolescent, Aged, 80 and over, Croatia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Equipment Design, Injections, Insulin, Patient Compliance, Patient Education, Patient Satisfaction, Questionnaires, Reproducibility of Results, Syringes
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
18 Apr 2024 : Clinical Research
Comparative Analysis of Open and Closed Sphincterotomy for the Treatment of Chronic Anal Fissure: Safety an...Med Sci Monit In Press; DOI: 10.12659/MSM.944127
08 Mar 2024 : Laboratory Research
Evaluation of Retentive Strength of 50 Endodontically-Treated Single-Rooted Mandibular Second Premolars Res...Med Sci Monit In Press; DOI: 10.12659/MSM.944110
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952